RECORD #647653


929571324 | DLMC | 87239485 | | 640360 | 0/1/2002 12:00:00 AM | CAD | | DIS | Admission Date: 7/14/2002 Report Status:

Discharge Date: 2/15/2002
****** DISCHARGE ORDERS ******
FERRON , WARD S 066-26-22-6
Fay Berke Ral
Service: CAR
DISCHARGE PATIENT ON: 8/18/02 AT 04:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: NAGODE , LEONARD GLEN , M.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
ALBUTEROL INHALER 2 PUFF INH QID PRN sob
ECASA ( ASPIRIN ENTERIC COATED ) 325 MG PO QD
FOLATE ( FOLIC ACID ) 1 MG PO QD
LASIX ( FUROSEMIDE ) 40 MG PO BID
Override Notice: Override added on 1/2/02 by
GORDILLO , DALLAS P. , M.D.
on order for DILTIAZEM PO ( ref # 35911429 )
POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL
Reason for override: will monitor
Previous override information:
Override added on 1/2/02 by CHICA , HUGO HERBERT , M.D.
on order for DILTIAZEM EXTENDED RELEASE PO ( ref #
86097748 )
POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL
Reason for override: will monitor
Previous override information:
Override added on 1/2/02 by HARMSEN , LAUREN JEROLD , M.D.
on order for DILTIAZEM PO ( ref # 27775445 )
POTENTIALLY SERIOUS INTERACTION: FUROSEMIDE &amp; DILTIAZEM HCL
Reason for override: md aware
HYDRALAZINE HCL 25 MG PO BID
Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
ZOCOR ( SIMVASTATIN ) 40 MG PO QHS
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
AMARYL ( GLIMEPIRIDE ) 2 MG PO QD
Number of Doses Required ( approximate ): 4
CLOPIDOGREL 75 MG PO QD Starting START THE NEXT DAY
AVAPRO ( IRBESARTAN ) 150 MG PO QD
Number of Doses Required ( approximate ): 4
DILTIAZEM SR 120 MG PO QOD
DIET: House / Low chol/low sat. fat
Activity - As tolerated
RETURN TO WORK: Immediately
FOLLOW UP APPOINTMENT( S ):
XTRH cardiology appointment will be arranged for 3 weeks ,
No Known Allergies
ADMIT DIAGNOSIS:
cad
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CAD
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
asthma CVA CAD Hemorrhagic stroke s/p CABG ( S/P cardiac bypass graft
surgery ) dm ( diabetes mellitus ) anxiety d/o
( anxiety ) osa ( sleep apnea ) hypercholesterolemia ( elevated
cholesterol ) htn ( hypertension )
OPERATIONS AND PROCEDURES:
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
Cardiac Catheterization with L PDA stenting
BRIEF RESUME OF HOSPITAL COURSE:
65 yo male with HTN , CAD , DM , and
hypercholesterolemia who presents with 3 episodes of exertional CP
over the last 3 days. On 7/4/02 the patient had his forst episode of
SSCP while pushing a grocery cart. It was associated
with SOB above the patient's baseline. There was
no associated n/v or diaphoresis. The pain
resolved over 45 minutes with rest. The pt.
again experienced exertional CP while walking on
Monday 7/19/02 .  The thrid episode of CP was onthe
morning of 3/18/02 while the patient descended stairs.
The pain was 7/10 and continued until the patient
saw his PCP shortly there after and was given two
SL NTG. EKG at PCP office was unchanged
from baseline. The patient reports that he has not
had CP similar to this since his CABG which was
in 1995. He denies PND , orthopnea , LE edema.
EXAM Notable for JVP of 8 cm , clear chest ,
regular cardaic exam and only trace edema in extremities.
No femoral bruits with 2+ dp and pt pulses.
HOSPITAL COURSE
Pt. went for left heart cath on 3/27/02 which
revea led a left dominant system with 80%
distal LCx/LPDA occlusion which was stanted; the cath
als o revealed 100% occlusion of SVG-LfPDA and
100 % SVG-marg 2and 70% prox. RCA.
PLAN 1. CV - ischemia - Continue home ischemia
regimen with ASA , avapro and zocor. B blocker
help secondary to asthma attack in past with
lopressor. Heparin held secondary to history of CVA
on anticoagulation.
Rate/rhythm - telemetry. Pump - No signs/sx. failure.
2. Renal - Baseline Cr 1.3; will recieve mucomyst for renal
protection with cath.
3. Endo - Will place the patient on RISS
and continue on amaryl.
4. Pulmonary - Will continue hime regimen of CPAP for OSA.
ADDITIONAL COMMENTS:
DISCHARGE CONDITION: Stable
TO DO/PLAN:
No dictated summary
ENTERED BY: BARTKUS , JOSEPH DESHAWN , M.D. ( HJ37 ) 8/18/02 @ 03:55 PM
****** END OF DISCHARGE ORDERS ******
[report_end]
